tirzepatide for heart failure with preserved ejection fraction and obesity benefits obese HFpEF patients without type 2 diabetes 📌 Most viewed this week

Fragoso, MD, Dartmouth Hitchcock Medical Center, Department of Dermatology Why Was This Research Done

3 In separate clinical studies of adults with overweight or obesity, about 1 in 4 taking Wegovy oral semaglutide 25 mg (64 weeks) and about 1 in 3 taking Wegovy injection 2.4 mg (68 weeks) lost 20% of body weight, alongside diet and exercise

Food stays in your stomach longer, so you tend to feel full for longer

They tend to be more effective because they bypass the digestive system, ensuring a higher concentration of the active drug reaches the bloodstream. GLP-1 pills have to battle stomach acid Of course, studies have shown that weight loss is a direct result of GLP-1 pills

Melanogenesis can protect the hypodermis, which is the layer beneath the skin, from harmful UV-B rays

Elderly people - With age, the body's ability to create glutathione decreases, which is why it is important to support its presence with dietary supplements